Author:
Fernández-González Raquel,Díaz López María Dolores,Lorenzo Vizcaya Ana María,González Noya Amara
Reference5 articles.
1. FDA Drug And Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin) [consultado en Sept 2019] Disponible en: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin
2. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure;Allen;N Eng J Med,1989
3. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia;Rhee;Eur Respir J,2013
4. Drug-induced eosinophilic pneumonia;Carmi;Medicine,2018
5. Daptomycin-induced eosinophilic pneumonia -a systematic review;Uppal;Antimicrob Resist Infect Control,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献